FREMGANGSMÅDE TIL FREMSTILLING AF [(5-(3-CHLORPHENYL)-3-HYDROXYPYRIDIN-2-CARBONYL)-AMINO]EDDIKESYRE FRA 5-((3-CHLORPHENYL)-3-CHLOR-PYRIDIN-2-YL)-NITRIL OG FREMGANGSMÅDE TIL FREMSTILLING AF 5-((HALOGENPHENYL)-3-HALOGEN-PYRIDIN-2-YL)-NITRILDERIVATER

The present invention relates to a process for preparing N-[[5-(3- chlorophenyl)-3-hydroxy-2-pyridinyl]carbonyl]-glycine (compound (5)), from the intermediates 5-(3-chlorophenyl)-3-chloro-2- pyridinecarbonitrile (compound (1)), 5-(3-chlorophenyl)-3-methoxy-2- pyridinecarbonitrile (compound (2)), 5-(...

Full description

Saved in:
Bibliographic Details
Main Authors JANUSZ, John, Michael, DIXON, Craig, Edward, COPP, James, Densmore, OUDENES, Jan, LANTHIER, Christopher, M, GORIN, Boris, LU, Alan, Qingbo
Format Patent
LanguageDanish
Published 06.12.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a process for preparing N-[[5-(3- chlorophenyl)-3-hydroxy-2-pyridinyl]carbonyl]-glycine (compound (5)), from the intermediates 5-(3-chlorophenyl)-3-chloro-2- pyridinecarbonitrile (compound (1)), 5-(3-chlorophenyl)-3-methoxy-2- pyridinecarbonitrile (compound (2)), 5-(3-chlorophenyl)-3-hydroxy-2- pyridinecarboxylic acid (compound (3)). Compound (5) is an intermediate in the preparation of prolyl hydroxylase inhibitors.
Bibliography:Application Number: DK20210004405T